Spatial analysis identifies DC niches as predictors of pembrolizumab therapy in head and neck squamous cell cancer.

Oh J, Hoelzl J, Carlson JCT, Bill R, Peterson HM, Faquin WC, Pittet MJ, Pai SI, Weissleder R

Open source

DOI
10.1016/j.xcrm.2025.102100
Published
2025 May 20
Container
Cell reports. Medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.xcrm.2025.102100,
  title = {Spatial analysis identifies DC niches as predictors of pembrolizumab therapy in head and neck squamous cell cancer.},
  author = {Oh J and Hoelzl J and Carlson JCT and Bill R and Peterson HM and Faquin WC and Pittet MJ and Pai SI and Weissleder R},
  year = {2025},
  journal = {Cell reports. Medicine},
  doi = {10.1016/j.xcrm.2025.102100},
  url = {https://doi.org/10.1016/j.xcrm.2025.102100}
}

RIS

TY  - JOUR
TI  - Spatial analysis identifies DC niches as predictors of pembrolizumab therapy in head and neck squamous cell cancer.
AU  - Oh J
AU  - Hoelzl J
AU  - Carlson JCT
AU  - Bill R
AU  - Peterson HM
AU  - Faquin WC
AU  - Pittet MJ
AU  - Pai SI
AU  - Weissleder R
PY  - 2025
JO  - Cell reports. Medicine
DO  - 10.1016/j.xcrm.2025.102100
UR  - https://doi.org/10.1016/j.xcrm.2025.102100
ER  - 

APA

J, O., J, H., JCT, C., R, B., HM, P., WC, F., MJ, P., SI, P., & R, W. (2025). Spatial analysis identifies DC niches as predictors of pembrolizumab therapy in head and neck squamous cell cancer.. Cell reports. Medicine. https://doi.org/10.1016/j.xcrm.2025.102100

Source records